Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,279 | 350 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,528 | 99 | $0 (2024) |
| Alkermes, Inc. | $1,288 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $732.42 | 30 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $719.76 | 33 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $523.95 | 28 | $0 (2024) |
| ITI, Inc. | $504.87 | 19 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $349.86 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $258.19 | 19 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $222.23 | 6 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $212.88 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,755 | 73 | ABBVIE INC. ($680.49) |
| 2023 | $3,637 | 157 | AbbVie Inc. ($998.66) |
| 2022 | $1,752 | 73 | Alkermes, Inc. ($447.62) |
| 2021 | $1,136 | 47 | AbbVie Inc. ($618.90) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: HIV | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Insomnia | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Neuroscience | ||||||
| 05/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 40 | 43 | $4,725 | $1,024 |
| 2021 | 4 | 185 | 223 | $20,199 | $8,868 |
| 2020 | 3 | 236 | 271 | $17,748 | $8,892 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 17 | $2,125 | $610.29 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 26 | $2,600 | $413.68 | 15.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 104 | $7,174 | $2,744 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 35 | $4,375 | $2,626 | 60.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 33 | 33 | $3,853 | $1,323 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 14 | $1,750 | $891.67 | 51.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 19 | $1,900 | $779.25 | 41.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 18 | 18 | $1,147 | $504.13 | 44.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2020 | 53 | 53 | $6,188 | $3,705 | 59.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 84 | 114 | $5,828 | $2,798 | 48.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 33 | $2,103 | $1,288 | 61.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 67 | 71 | $3,630 | $1,101 | 30.3% |
About Marie Adolphe, ARNP
Marie Adolphe, ARNP is a Family healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1881993863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Marie Adolphe, ARNP has received a total of $8,279 in payments from pharmaceutical and medical device companies, with $1,755 received in 2024. These payments were reported across 350 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($8,279).
As a Medicare-enrolled provider, Adolphe has provided services to 461 Medicare beneficiaries, totaling 537 services with total Medicare billing of $18,784. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Psychiatric/Mental Health
- Location Kissimmee, FL
- Active Since 03/16/2011
- Last Updated 05/28/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1881993863
Products in Payments
- VRAYLAR (Drug) $2,481
- LYBALVI (Drug) $860.90
- CAPLYTA (Drug) $727.10
- REXULTI (Drug) $431.62
- ARISTADA (Drug) $427.54
- SPRAVATO (Drug) $388.60
- INGREZZA (Drug) $349.86
- INVEGA SUSTENNA (Drug) $317.86
- TRINTELLIX (Drug) $258.19
- ABILIFY MAINTENA (Drug) $244.27
- Austedo XR (Drug) $217.44
- UZEDY (Drug) $193.98
- HETLIOZ (Drug) $191.14
- ABILIFY ASIMTUFII (Drug) $169.56
- QUVIVIQ (Drug) $154.27
- PERSERIS (Drug) $125.75
- VNS Therapy Symmetry Model 8103 Generator (Device) $120.16
- AUSTEDO (Drug) $112.53
- LATUDA (Drug) $105.70
- JORNAY PM (Drug) $96.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Kissimmee
Roger Rivera, Dnp, DNP
Family — Payments: $1.1M
Mrs. Reena Varghese, Arnp, ARNP
Family — Payments: $16,376
Dr. Trinese Hardy, Drph, Pmhnp, Fnp, DRPH, PMHNP, FNP
Family — Payments: $12,076
Mailen Broche, Aprn, APRN
Family — Payments: $6,558
Patricia Lopez
Family — Payments: $5,877
Mrs. Marilyn Velez, Arnp, ARNP
Family — Payments: $5,635